The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Biweekly Oxaliplatin (L-OHP) with High-Dose Leucovorin (LV) and 5-Fluorouracil (5-FU) in Irinotecan Pretreated Patients with Advanced Colorectal Cancer (ACC). 

Pat  Gulhati

No Relationships to Disclose

Laura  Prakash

No Relationships to Disclose

Matthew H. G.  Katz

Consulting or Advisory Role - Abbvie; Alcresta Therapeutics; McKesson

Xuemei  Wang

No Relationships to Disclose

Rachna T.  Shroff

Consulting or Advisory Role - Agios; Amgen; Celgene; Codiak Biosciences; Halozyme

Research Funding - Agios; Celgene; Lilly

Travel, Accommodations, Expenses - Agios; Amgen; Celgene; Codiak Biosciences; Halozyme

David R.  Fogelman

Stock and Other Ownership Interests  - GTx

Consulting or Advisory Role - Incyte

Jeffrey Edwin  Lee

No Relationships to Disclose

Ching-Wei David  Tzeng

No Relationships to Disclose

Jeffrey H  Lee

Honoraria - Boston Scientific

Consulting or Advisory Role - Boston Scientific

Research Funding - Olympus

Travel, Accommodations, Expenses - Boston Scientific

Brian  Weston

No Relationships to Disclose

Eric P.  Tamm

Research Funding - GE Healthcare (Inst)

Priya  Bhosale

No Relationships to Disclose

Eugene Jon  Koay

Honoraria - Philips Healthcare

Research Funding - Philips Healthcare

Anirban  Maitra

Research Funding - Opsona Therapeutics (Inst)

Huamin  Wang

No Relationships to Disclose

Robert A.  Wolff

Honoraria - Precision Medicine Research Associates, LLC

Consulting or Advisory Role - Clovis Oncology; Precision Medicine Research Associates, LLC

Patents, Royalties, Other Intellectual Property - Royalties from McGraw-Hill: Editor: M.D. Anderson Manual of Medical Oncology, 3rd edition.

Gauri R.  Varadhachary

Employment - Fannin Partners (I)

Leadership - Fannin Partners (I); Pulmotect (I)

Stock and Other Ownership Interests  - Fannin Partners (I)

Honoraria - Celgene; Merrimack; Momenta Pharmaceuticals; Rexahn Pharmaceuticals

Consulting or Advisory Role - Celgene; Merrimack; Momenta Pharmaceuticals; Rexahn Pharmaceuticals

Research Funding - Merck (Inst)

Patents, Royalties, Other Intellectual Property - Spouse is an inventor of use patents relating to recombinant human lactoferrin. The molecule is no longer in development and patents are being allowed to lapse as payments come due. (I); Spouse is inventor on a pending patent for an ELISA diagnostic platform. Not related to my area of research. (I)

Travel, Accommodations, Expenses - Celgene and Merrimack